This is StromaBio

StromaBio AB is a clinical stage biopharma company developing Mesenchymal Stromal Cell (MSC) based cell therapies. Founded on more than two decades of world leading research, our aim is to bring new advanced therapies to patients with Acute Respiratory Distress Syndrome (ARDS), and neurodegenerative Alzheimer’s Disease (AD).

Mesenchymal stromal cells (MSCs) are adult multipotent stem cells capable of differentiation to multiple cell types with anti-inflammatory, immune-modulatory and regenerative characteristics, making them optimal candidates for treatment of multiple diseases.

Our bone marrow derived product is classified as an allogenic advanced therapy medicinal product (ATMP) with more than ten years of pre-clinical and clinical research. The compelling results and our highly merited research team lay a strong foundation for our clinical path ahead.

Our Science

Our team is growing at a high pace and we are always looking for new talent.

Do you want to make an impact on the future development of cell therapeutics? Are you ready for a new challenge? Please don’t hesitate to reach out to us.